Bagheri H - Search Results

1

Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.

Tavassoli N, Bagheri H, Sommet A, Delpierre C, Marion-Latard F, Massip P, Aquilina C, Bonnet E, Obadia M, Labau E, Montastruc JL, Bernard J. Tavassoli N, et al. Among authors: bagheri h. Pharmacotherapy. 2006 Feb;26(2):154-61. doi: 10.1592/phco.26.2.154. Pharmacotherapy. 2006. PMID: 16466321

2

Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients.

Cestac P, Bagheri H, Lapeyre-Mestre M, Sié P, Fouladi A, Maupas E, Léger P, Fontan B, Massip P, Montastruc JL. Cestac P, et al. Among authors: bagheri h. Drug Saf. 2003;26(3):197-207. doi: 10.2165/00002018-200326030-00005. Drug Saf. 2003. PMID: 12580648

3

Adverse drug reactions to anthelmintics.

Bagheri H, Simiand E, Montastruc JL, Magnaval JF. Bagheri H, et al. Ann Pharmacother. 2004 Mar;38(3):383-8. doi: 10.1345/aph.1D325. Epub 2004 Jan 23. Ann Pharmacother. 2004. PMID: 14749518

4

Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy.

Bagheri H, Fouladi A, Barange K, Lapeyre-Mestre M, Payen JL, Montastruc JL, Vinel JP. Bagheri H, et al. Pharmacotherapy. 2004 Nov;24(11):1546-53. doi: 10.1592/phco.24.16.1546.50947. Pharmacotherapy. 2004. PMID: 15537560

5

Trimetazidine: a new cause for drug-induced parkinsonism?

Sommet A, Azaïs-Vuillemin C, Bagheri H, Rascol O, Montastruc JL. Sommet A, et al. Among authors: bagheri h. Mov Disord. 2005 Aug;20(8):1080-1. doi: 10.1002/mds.20574. Mov Disord. 2005. PMID: 16007626 No abstract available.

6

[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance].

Montastruc JL, Sommet A, Olivier P, Bagheri H, Gony M, Lapeyre-Mestre M, Brefel-Courbon C, Ferreira J, Schmitt L, Senard JM, Rascol O. Montastruc JL, et al. Among authors: bagheri h. Therapie. 2006 Jan-Feb;61(1):29-38. doi: 10.2515/therapie:2006011. Therapie. 2006. PMID: 16792152 French.

7

[Analysis of antiretroviral drugs-induced adverse effects].

Baudrant M, Bagheri H, Cuzin L, Sommet A, Bassoua V, Guitton E, Bonnet E, Garipuy D, Lucas F, Aquilina C, Montastruc JL, Massip P. Baudrant M, et al. Among authors: bagheri h. Therapie. 2006 Mar-Apr;61(2):171-6. Therapie. 2006. PMID: 16886711 French.

8

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Montastruc JL, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M, Bagheri H. Montastruc JL, et al. Among authors: bagheri h. Joint Bone Spine. 2006 Dec;73(6):629-32. doi: 10.1016/j.jbspin.2006.09.002. Epub 2006 Oct 12. Joint Bone Spine. 2006. PMID: 17110152 Review. No abstract available.

9

Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).

Tavassoli N, Sommet A, Lapeyre-Mestre M, Bagheri H, Montrastruc JL. Tavassoli N, et al. Among authors: bagheri h. Drug Saf. 2007;30(11):1063-71. doi: 10.2165/00002018-200730110-00005. Drug Saf. 2007. PMID: 17973542

10

Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.

Bürki F, Badie K, Bartoli P, Bernard P, Montastruc JL, Bagheri H. Bürki F, et al. Among authors: bagheri h. Br J Clin Pharmacol. 2008 May;65(5):793-4. doi: 10.1111/j.1365-2125.2008.03119.x. Epub 2008 Feb 15. Br J Clin Pharmacol. 2008. PMID: 18279475 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

657 results

Search Page

Filters